Free Trial

Schrödinger Q1 2023 Earnings Report

Schrödinger logo
$22.64 -1.36 (-5.67%)
As of 02/21/2025 04:00 PM Eastern

Schrödinger EPS Results

Actual EPS
-$0.38
Consensus EPS
$1.36
Beat/Miss
Missed by -$1.74
One Year Ago EPS
N/A

Schrödinger Revenue Results

Actual Revenue
$64.78 million
Expected Revenue
$66.80 million
Beat/Miss
Missed by -$2.02 million
YoY Revenue Growth
N/A

Schrödinger Announcement Details

Quarter
Q1 2023
Time
N/A

SDGR Upcoming Earnings

Schrödinger will be holding an earnings conference call on Wednesday, February 26 at 4:30 PM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

Schrödinger Earnings Headlines

Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
See More Schrödinger Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Schrödinger? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Schrödinger and other key companies, straight to your email.

About Schrödinger

Schrödinger (NASDAQ:SDGR), together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

View Schrödinger Profile

More Earnings Resources from MarketBeat